The FDA has issued recent updates on several drugs that are currently in shortage or have been discontinued:
- Aminocaproic Acid Injection, USP (Updated – Currently in Shortage)
- Aminophylline Injection, USP (Updated – Currently in Shortage)
- Atropine Sulfate Injection (Updated – Currently in Shortage)
- Bupivacaine Hydrochloride and Epinephrine Injection, USP (Updated – Currently in Shortage)
- Bupivacaine Hydrochloride Injection, USP (Updated – Currently in Shortage)
- Calcium Chloride Injection, USP (Updated – Currently in Shortage)
- Dextrose 5% Injection Bags (Updated – Currently in Shortage)
- Diazepam Injection, USP (Updated – Currently in Shortage)
- Diltiazem Hydrochloride (Updated – Currently in Shortage)
- Dobutamine Hydrochloride Injection (Updated – Currently in Shortage)
- Dopamine Hydrochloride Injection (Updated – Currently in Shortage)
- Epinephrine Injection, 0.1 mg/mL (Updated – Currently in Shortage)
- Fentanyl Citrate (Sublimaze) Injection (Updated – Currently in Shortage)
- Fluorescein Injection (Updated – Currently in Shortage)
- Fluorescein Sodium Injection (Updated – Currently in Shortage)
- Hydromorphone Hydrochloride Injection, USP (Updated – Currently in Shortage)
- Ketorolac Tromethamine Injection (Updated – Currently in Shortage)
- Labetalol Hydrochloride Injection (Updated – Currently in Shortage)
- Lidocaine Hydrochloride (Xylocaine) Injection (Updated – Currently in Shortage)
- Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine (Updated – Currently in Shortage)
- Lorazepam Injection, USP (Updated – Currently in Shortage)
- Magnesium Sulfate Injection (Updated – Currently in Shortage)
- Metoclopramide Injection, USP (Updated – Currently in Shortage)
- Metronidazole Injection, USP (Updated – Currently in Shortage)
- Morphine Sulfate Injection, USP (Updated – Currently in Shortage)
- Multi-Vitamin Infusion (Adult and Pediatric) (Updated – Currently in Shortage)
- Ondansetron Hydrochloride Injection (Updated – Currently in Shortage)
- Piperacillin and Tazobactam (Zosyn) Injection (Updated – Currently in Shortage)
- Potassium Chloride Injection (Updated – Currently in Shortage)
- Procainamide Hydrochloride Injection, USP (Updated – Currently in Shortage)
- Promethazine (Phenergan) Injection (Updated – Currently in Shortage)
- Ropivacaine Hydrochloride Injection (Updated – Currently in Shortage)
- Sacrosidase (Sucraid) Oral Solution (Updated – Currently in Shortage)
- Sodium Acetate Injection, USP (Updated – Currently in Shortage)
- Sodium Chloride 0.9% Injection Bags (Currently in Shortage)
- Sodium Chloride 23.4% Injection (Updated – Currently in Shortage)
- Sodium Chloride Injection USP, 0.9% Vials and Syringes (Updated – Currently in Shortage)
- Sterile Water (Updated – Currently in Shortage)
- Trazodone Hydrochloride Tablets (Discontinuation)
- Valsartan Tablets (New – Currently in Shortage)
According to the FDA:
“A drug receives Resolved status when the Drug Shortages Staff (DSS) determines that the market is covered, based on information from all manufacturers. The market is considered covered when supply is available from at least one manufacturer to cover total market demand. However, some manufacturers may not have all presentations available. DSS monitors the supply of products with Resolved status. For the most current supply information, contact the manufacturers.”
(Source: U.S. Food & Drug Adminstration)
Follow us on Twitter and Facebook for updates on the latest pharmaceutical and biopharmaceutical manufacturing news!
